🇺🇸 AST-120 in United States

12 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Hepatic Function Abnormal — 2 reports (16.67%)
  2. Renal Impairment — 2 reports (16.67%)
  3. Abdominal Pain Lower — 1 report (8.33%)
  4. Alanine Aminotransferase Increased — 1 report (8.33%)
  5. Amnesia — 1 report (8.33%)
  6. Anaemia — 1 report (8.33%)
  7. Ascites — 1 report (8.33%)
  8. Aspartate Aminotransferase Increased — 1 report (8.33%)
  9. Asthenia — 1 report (8.33%)
  10. Cardiac Failure Acute — 1 report (8.33%)

Source database →

AST-120 in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is AST-120 approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for AST-120 in United States?

Ocera Therapeutics is the originator. The local marketing authorisation holder may differ — check the official source linked above.